![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
FDA extend review timeline for vandetanib new drug application
AstraZeneca announced that the US Food and Drug Administration (FDA) has extended the time to...
Daxas (Roflumilast) included as a new treatment option in latest international COPD guidelines
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has included roflumilast (Daxas®) as a...
Merck to Hold Fourth-Quarter 2010 Sales and Earnings Conference Call on Feb. 3
Merck will hold its fourth-quarter 2010 sales and earnings conference call with institutional investors and...
Teva Completes Acquisition of Theramex
Teva Pharmaceutical Industries Ltd. announced that it has completed the acquisition of Theramex, Merck KGaA's...
Novartis drug Tasigna received approval from the European Commission
Novartis received approval from the European Commission for Tasigna® (nilotinib) as a treatment for adult...
Arena and Eisai Complete End-of-Review Meeting with FDA
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today the completion of an end-of-review meeting with...
Lundbeck enters into drug discovery collaboration with Zenobia and Vernalis
H. Lundbeck A/S announced that it has signed agreements with Zenobia Therapeutics (Zenobia) and Vernalis...
Merck Serono and San Raffaele Institute to Collaborate on Research
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced a strategic collaboration with the...
Addex Awarded EuropaBio’s Most Innovative SME Award
Allosteric modulation company Addex Pharmaceuticals announced that the company has been awarded EuropaBio’s Most Innovative...
Fluxion Biosciences Announces Product Launch of BioFlux 1000Z
Fuxion Biosciences, Inc. announced that the new BioFlux 1000Z system for live cell imaging will...